Lumina Fund Management’s CVS Health CVS Stock Holding History

Lumina Fund Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,000	Closed	-$338K	–	40
2019 Q1	$338K	Buy	+5,000	New	+$309K	0.2%	32

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lumina Fund Management's CVS Position: Q4 2023 in Review

Lumina Fund Management sold out of CVS Health (CVS) in Q4 2023, closing a stake of 20,000 shares — an estimated $1.4M sold.

Lumina Fund Management first reported a position in CVS in Q1 2018 and held it in 21 quarters. The position peaked at $4.5M in Q2 2018. 2,258 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

Lumina Fund Management reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
Lumina Fund Management sold 20,000 CVS Health shares in Q4 2023, an estimated $1.4M.
Lumina Fund Management first reported a position in CVS Health in Q1 2018 and held it in 21 quarters.
Lumina Fund Management's CVS Health position peaked at $4.5M in Q2 2018.
2,258 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Lumina Fund Management's 13F filing for Q4 2023, filed 2 Feb 2024.